SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000950170-24-045612
Filing Date
2024-04-18
Accepted
2024-04-18 16:42:22
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-3 srzn_s3_04182024.htm S-3 416897
2 EX-5.1 srzn-ex5_1.htm EX-5.1 25216
3 EX-23.1 srzn-ex23_1.htm EX-23.1 3878
4 EX-FILING FEES srzn-exfiling_fees.htm EX-FILING FEES 19321
5 GRAPHIC img200110477_0.jpg GRAPHIC 29364
  Complete submission text file 0000950170-24-045612.txt   507063
Mailing Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-475-2820
Surrozen, Inc./DE (Filer) CIK: 0001824893 (see all company filings)

IRS No.: 301374889 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-278800 | Film No.: 24854804
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)